©The Author(s) 2026.
World J Gastrointest Pharmacol Ther. Mar 5, 2026; 17(1): 112615
Published online Mar 5, 2026. doi: 10.4292/wjgpt.v17.i1.112615
Published online Mar 5, 2026. doi: 10.4292/wjgpt.v17.i1.112615
Table 2 Pharmacokinetics of proton pump inhibitors
| Agents | Bioavailability (%) | Tmax (hour) | Cmax (mg/mL) | Protein binding (%) | T1/2 (hour) | pKa | AUC 0-24 (mg/hour/L) | V (L/kg) | CL (mL/minute) |
| Esomeprazole | 64-90 | 1.5 | 1.5 | 97 | 1-1.5 | 4.0 | 2.0 | 160-330 | 1.3-1.6 |
| Dexlansoprazole | - | 4-5 | - | 96 | 1-2 | 4.0 | - | - | - |
| Pantoprazole | 77 | 2-3 | 2.5 | 98 | 1-1.9 | 3.9 | 5.0 | 90-225 | 0.8-2.0 |
| Rabeprazole | 52 | 2-5 | 0.4 | 96.3 | 1-2 | 5.0 | 0.8 | - | 0.6-1.4 |
| Omeprazole | 30-40 | 0.5-3.5 | 0.7 | 95 | 0.5-1 | 4.0 | 2.0 | 400-620 | 0.5-1.2 |
| Lansoprazole | 80-85 | 1.7 | 0.5-1.0 | 97 | 1.6 | 4.0 | 2.5 | 400-650 | 0.9-2.1 |
- Citation: Sinha SK, Kochhar R, Rao KS, Yadav D, Ray S, Singh AP, Sethy PK, Mahajan R, Reddy DV, Sharma VM, Kumar A, Mishra A, Jain S, Swami OC, Patil D. Acid peptic disorder compass: An Indian expert consensus on comprehensive management. World J Gastrointest Pharmacol Ther 2026; 17(1): 112615
- URL: https://www.wjgnet.com/2150-5349/full/v17/i1/112615.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v17.i1.112615